Work

Abstract OT1-02-04: Enfortumab vedotin 202: Phase 2 study of enfortumab vedotin for previously treated advanced solid tumors, including breast cancer

Year: 2022

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs21-ot1-02-04

Authors: Makiko Ono, Justine Yang Bruce, Trevor Feinstein, Kei Muro, Christina Derleth, Seema Gorla, Chunzhang Wu, Yelena Novik

Institutions: The Cancer Institute Hospital, Japanese Foundation For Cancer Research, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Piedmont Cancer Institute, Aichi Cancer Center, Seagen (United States), Astellas Pharma (United States), NYU Langone Health

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4221046823

Cites:

Cited by: 2

Related to: 10